{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:53:06Z","timestamp":1768409586593,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.069","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T09:11:04Z","timestamp":1428311464000},"page":"2301-2306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?"],"prefix":"10.1016","volume":"33","author":[{"given":"R.","family":"Michel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2177-801X","authenticated-orcid":false,"given":"F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ravelonarivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dussart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rogier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Moua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.D.","family":"Sarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.M.","family":"Diop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Sall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Baril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2015.03.069_bib0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jmv.1890190403","article-title":"Simultaneous administration of hepatitis B and yellow fever vaccines","volume":"19","author":"Yvonnet","year":"1986","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.069_bib0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0264-410X(86)90004-6","article-title":"Comparative clinical study of a new 17D thermostable yellow fever vaccine","volume":"4","author":"Roche","year":"1986","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.069_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0092-1157(88)90034-0","article-title":"Studies on yellow fever vaccine. III \u2013 Dose response in volunteers","volume":"16","author":"Lopes Ode","year":"1988","journal-title":"J Biol Stand"},{"issue":"5","key":"10.1016\/j.vaccine.2015.03.069_bib0175","first-page":"406","article-title":"Vaccination simultan\u00e9e contre l\u2019h\u00e9patite A et la fi\u00e8vre jaune","volume":"86","author":"Receveur","year":"1993","journal-title":"Bull Soc Pathol Exot"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.069_bib0180","first-page":"160","article-title":"Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever+yellow fever vaccine","volume":"14","author":"Dumas","year":"1997","journal-title":"Adv Ther"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2015.03.069_bib0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0190","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever","author":"Monath","year":"2004"},{"issue":"6","key":"10.1016\/j.vaccine.2015.03.069_bib0195","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0200","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4269\/ajtmh.1963.12.230","article-title":"Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine","volume":"12","author":"Rosenzweig","year":"1963","journal-title":"Am J Trop Med Hyg"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2015.03.069_bib0205","first-page":"153","article-title":"Assessment of yellow fever epidemic risk \u2013 a decision-making tool for preventive immunization campaigns","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2015.03.069_bib0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1997.0056","article-title":"Yellow fever vaccines","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"issue":"9276","key":"10.1016\/j.vaccine.2015.03.069_bib0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2015.03.069_bib0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.1966.03110190153047","article-title":"Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child","volume":"198","year":"1966","journal-title":"JAMA"},{"issue":"9276","key":"10.1016\/j.vaccine.2015.03.069_bib0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"July (9276)","key":"10.1016\/j.vaccine.2015.03.069_bib0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"30","key":"10.1016\/j.vaccine.2015.03.069_bib0235","first-page":"643","article-title":"Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996\u20132001","volume":"50","author":"Centers for Disease Control and Prevention (CDC)","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"10.1016\/j.vaccine.2015.03.069_bib0240","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1016\/j.vaccine.2014.08.051","article-title":"Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)","volume":"32","author":"Seligman","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.069_bib0245","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"November (RR-17)","key":"10.1016\/j.vaccine.2015.03.069_bib0250","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0255","first-page":"226","article-title":"Recommandations sanitaires pour les voyageurs 2008 (\u00e0 l\u2019attention des professionnels de sant\u00e9)","volume":"25\/26","year":"2008","journal-title":"Bull Epidemiol Hebdo"},{"issue":"8","key":"10.1016\/j.vaccine.2015.03.069_bib0260","first-page":"66","article-title":"Progress towards elimination of measles and prevention of congenital rubella infection in the WHO European Region, 1990\u20132004","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0265","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(05)67216-9","article-title":"Public-health impact of accelerated measles control in the WHO African Region 2000\u201303","volume":"366","author":"Otten","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0270","series-title":"Aspects pratiques des vaccinations. Guide des vaccinations 2008","first-page":"95","author":"Direction G\u00e9n\u00e9rale de la Sant\u00e9. Comit\u00e9 technique des Vaccinations","year":"2008"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1056\/NEJM196507222730405","article-title":"Circulating interferon after measles vaccination","volume":"273","author":"Petralli","year":"1965","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.069_bib0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09629350310001599639","article-title":"Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination","volume":"12","author":"Pukhalsky","year":"2003","journal-title":"Mediators Inflamm"},{"issue":"March (9\/10)","key":"10.1016\/j.vaccine.2015.03.069_bib0285","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0264-410X(98)00320-X","article-title":"Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine","volume":"17","author":"Stefano","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0290","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/AEM.16.11.1770-1775.1968","article-title":"Yellow fever virus. I. Development and evaluation of a plaque neutralization test","volume":"16","author":"Spector","year":"1968","journal-title":"Appl Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.069_bib0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/2051013613498954","article-title":"Advances and controversies in yellow fever vaccination","volume":"1","author":"Jonker","year":"2013","journal-title":"Ther Adv Vaccines"},{"issue":"7409","key":"10.1016\/j.vaccine.2015.03.069_bib0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(65)90755-5","article-title":"Action of endogenous interferon against vaccinia infection in children","volume":"2","author":"Petralli","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.069_bib0305","series-title":"Red book: report of the committee on infectious diseases","first-page":"1","article-title":"Active and passive immunization","author":"American Academy of Pediatrics","year":"1997"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.069_bib0310","first-page":"227","article-title":"Interference between measles and poliomyelitis vaccines","volume":"103","author":"Pannuti","year":"1987","journal-title":"Bol Oficina Sanit Panam"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T14:12:51Z","timestamp":1598883171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15003886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":31,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15003886"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}